O Shaughnessy Asset Management LLC acquired a new position in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 18,429 shares of the company’s stock, valued at approximately $242,000.
Other large investors have also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. raised its position in shares of Pediatrix Medical Group by 95.3% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after buying an additional 1,220 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in Pediatrix Medical Group by 36.1% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares in the last quarter. AlphaQuest LLC lifted its position in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its stake in Pediatrix Medical Group by 750.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after purchasing an additional 6,090 shares in the last quarter. Finally, FMR LLC increased its position in shares of Pediatrix Medical Group by 220.6% during the 3rd quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after purchasing an additional 6,771 shares during the period. 97.71% of the stock is currently owned by institutional investors and hedge funds.
Pediatrix Medical Group Stock Performance
Pediatrix Medical Group stock opened at $13.35 on Friday. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The firm’s 50 day simple moving average is $14.33 and its 200-day simple moving average is $13.91. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The company has a market cap of $1.15 billion, a P/E ratio of -11.13, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32.
Analyst Upgrades and Downgrades
MD has been the subject of several research analyst reports. Truist Financial cut their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a report on Friday. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Macquarie began coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective on the stock. Finally, StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of “Hold” and an average price target of $16.75.
Get Our Latest Stock Report on MD
Pediatrix Medical Group Company Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Further Reading
- Five stocks we like better than Pediatrix Medical Group
- How to trade penny stocks: A step-by-step guide
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- How to Invest in Blue Chip Stocks
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.